Emerald Advisers’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-103,850	Closed	-$4.66M	–	278
2021 Q2	$4.66M	Buy	+103,850	New	+$4.66M	0.17%	121